COBRE Phase 1 Funding Opportunities for Data Sciences and Women’s Health Research and Upcoming Webinar


UPDATE: The webinar slides [PDF] and video are now available.

We’re pleased to announce that we’ve published two notices of special interest (NOSIs) requesting applications to PAR-22-250, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), to build research capacity in data sciences (NOT-GM-23-011) and women’s health (NOT-GM-23-012) in IDeA states.

These NOSIs highlight the Office of Data Science Strategy’s interest in supporting meritorious applications on data science relevant to biomedical research, and the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health.

Next application receipt date: January 30, 2023
Earliest start date: December 2023

We strongly encourage all potential Phase 1 COBRE applicants and institutional officials interested in applying to either of these NOSIs to attend our upcoming webinar:

Wednesday, November 16, 1:00-2:30 p.m. ET
Zoom Meeting link
Meeting ID: 161 130 4345
Passcode: 292760

If you’re unable to attend online, you can join by calling 669-254-5252 or 551-285-1373 and entering the meeting ID and passcode.  

During the webinar, we’ll present a brief overview of the COBRE Phase 1 program in context to these NOSIs. We’ll also answer your questions.

Participants are encouraged to submit questions prior to the webinar by contacting me no later than November 15. Those requiring sign language interpretation and/or other reasonable accommodations should submit a request using our contact form at least 5 days prior to the webinar.

The webinar and presentation slides will be posted on the COBRE webpage following the event.

Submit a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.